STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #962 by analyst upside · 2026-08-13
CELC
Celcuity Inc.
Healthcare · Market Cap $4B · P/E 0x
ANALYST PRICE TARGET
+77.6%
implied upside to consensus target
Current Price $92.08
Consensus Target $163.54
Bull Target $178.0
Bear Target $148.0
Analysts Covering 11
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
9
Hold
0
Sell
0
52-Week Low $44.42
52-Week High $151.02
YTD Return -8.4%
FUNDAMENTALS
Market Cap $4B
P/E Ratio (TTM) N/A
Forward P/E 95.9x
EPS (TTM) $-3.90
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $44.42
52-Week High $151.02
Current Price $92.08
Bear Target $148.0
Bull Target $178.0
● Now $92.08 ● Target $163.54
TRADING DATA
Avg Volume 1.5M
YTD Return -8.4%
Analyst Count 11
Consensus Buy
Upside to Target +77.6%
Last Updated 2026-08-13

ANALYST SUMMARY

Celcuity Inc. (CELC) is currently trading at $92.08 with a Wall Street consensus price target of $163.54, implying potential upside of 77.6% over the next 12 months. 11 analysts currently cover CELC, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $178.0, while the most cautious has a target of $148.0.

CELC operates in the Healthcare sector with a market capitalisation of $4B. The stock is down 8.4% year-to-date and is currently trading near the lower end of its 52-week range of $44.42 – $151.02.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CELC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Craig-Hallum - Reiterated
Buy → Buy 2026-06-03 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-06-03 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-06-03 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-05-18 31% win rate (48 calls)
Wells Fargo - Reiterated
Overweight → Overweight 2026-05-15 Building track record
Needham reit
Buy → Buy 2026-05-15 20% win rate (5 calls)
Citizens - Reiterated
Market Outperform → Market Outperform 2026-05-04 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-05-04 62% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
69
out of 100
Coverage depth
19/30
Consensus clarity
23/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →